Versant Capital Management’s Amphastar Pharmaceuticals AMPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $4.4K | Hold |
218
| – | – | ﹤0.01% | 2453 |
|
|
2026
Q1 | $4.27K | Sell |
218
-144
| -40% | -$3.52K | ﹤0.01% | 2424 |
|
|
2025
Q4 | $9.69K | Buy |
362
+71
| +24% | +$1.83K | ﹤0.01% | 2009 |
|
|
2025
Q3 | $7.75K | Sell |
291
-333
| -53% | -$8.6K | ﹤0.01% | 2039 |
|
|
2025
Q2 | $14.3K | Buy |
624
+268
| +75% | +$6.65K | ﹤0.01% | 1708 |
|
|
2025
Q1 | $10.3K | Buy |
356
+135
| +61% | +$4.31K | ﹤0.01% | 1714 |
|
|
2024
Q4 | $8.21K | Sell |
221
-47
| -18% | -$2.15K | ﹤0.01% | 1514 |
|
|
2024
Q3 | $13K | Hold |
268
| – | – | ﹤0.01% | 966 |
|
|
2024
Q2 | $10.7K | Hold |
268
| – | – | ﹤0.01% | 956 |
|
|
2024
Q1 | $11.8K | Hold |
268
| – | – | ﹤0.01% | 711 |
|
|
2023
Q4 | $16.6K | Sell |
268
-98
| -27% | -$5.15K | ﹤0.01% | 557 |
|
|
2023
Q3 | $16.8K | Sell |
366
-60
| -14% | -$3.27K | 0.01% | 538 |
|
|
2023
Q2 | $24.5K | Sell |
426
-30
| -7% | -$1.33K | 0.01% | 441 |
|
|
2023
Q1 | $17.1K | Sell |
456
-18
| -4% | -$590 | 0.01% | 539 |
|
|
2022
Q4 | $13.3K | Hold |
474
| – | – | ﹤0.01% | 591 |
|
|
2022
Q3 | $13K | Sell |
474
-1
| -0.2% | -$33 | 0.01% | 558 |
|
|
2022
Q2 | $17K | Sell |
475
-41
| -8% | -$1.46K | 0.01% | 469 |
|
|
2022
Q1 | $19K | Sell |
516
-48
| -9% | -$1.36K | 0.01% | 476 |
|
|
2021
Q4 | $13K | Buy |
564
+61
| +12% | +$1.25K | ﹤0.01% | 629 |
|
|
2021
Q3 | $10K | Sell |
503
-46
| -8% | -$901 | ﹤0.01% | 686 |
|
|
2021
Q2 | $11K | Buy |
549
+76
| +16% | +$1.43K | ﹤0.01% | 671 |
|
|
2021
Q1 | $9K | Hold |
473
| – | – | ﹤0.01% | 805 |
|
|
2020
Q4 | $9K | Hold |
473
| – | – | ﹤0.01% | 743 |
|
|
2020
Q3 | $8K | Hold |
473
| – | – | ﹤0.01% | 718 |
|
|
2020
Q2 | $10K | Buy |
473
+10
| +2% | +$183 | ﹤0.01% | 614 |
|
|
2020
Q1 | $6K | Buy |
+463
| New | +$8.06K | ﹤0.01% | 692 |
|
|
2019
Q1 | – | Sell |
-22
| Closed | – | – | 1543 |
|
|
2018
Q4 | $0 | Buy |
22
+10
| +83% | +$197 | ﹤0.01% | 1461 |
|
|
2018
Q3 | $0 | Sell |
12
-3
| -20% | -$53 | ﹤0.01% | 1506 |
|
|
2018
Q2 | $0 | Hold |
15
| – | – | ﹤0.01% | 1496 |
|
|
2018
Q1 | $0 | Sell |
15
-28
| -65% | -$526 | ﹤0.01% | 1474 |
|
|
2017
Q4 | $0 | Hold |
43
| – | – | ﹤0.01% | 1517 |
|
|
2017
Q3 | $0 | Sell |
43
-187
| -81% | -$3.08K | ﹤0.01% | 1433 |
|
|
2017
Q2 | $4K | Buy |
+230
| New | +$3.65K | ﹤0.01% | 1084 |
|
Other funds holding AMPH
Versant Capital Management's AMPH Position: Q2 2026 in Review
Versant Capital Management held its Amphastar Pharmaceuticals (AMPH) position steady in Q2 2026 at 218 shares worth $4.4K. The position accounts for ﹤0.01% of the portfolio, ranked #2453.
Versant Capital Management first reported a position in AMPH in Q2 2017 and has held it in 33 quarters since. The position peaked at $24.5K in Q2 2023. 211 funds tracked by Wall St. Rank hold AMPH as of Q2 2026.
- Versant Capital Management held 218 shares of Amphastar Pharmaceuticals worth $4.4K as of Q2 2026.
- Versant Capital Management left its Amphastar Pharmaceuticals share count unchanged in Q2 2026.
- Amphastar Pharmaceuticals made up ﹤0.01% of Versant Capital Management's portfolio in Q2 2026, its #2453 holding.
- Versant Capital Management first reported a position in Amphastar Pharmaceuticals in Q2 2017 and has held it in 33 quarters since.
- Versant Capital Management's Amphastar Pharmaceuticals position peaked at $24.5K in Q2 2023.
- 211 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q2 2026.
Based on Versant Capital Management's 13F filing for Q2 2026, filed 2 Jul 2026.